Savient Pharmaceuticals Inc Com (NASDAQOTH:SVNTQ)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Results 1 - 20 of 65 : 1 2 3 4 Next »

Recs

0
Member Avatar CarlosDK (20.68) Submitted: 11/15/2012 6:11:18 AM : Outperform Start Price: $1.13 SVNTQ Score: -151.71

IHS on finviz

Recs

3
Member Avatar HoldThatWinner (30.82) Submitted: 5/3/2012 10:25:32 AM : Outperform Start Price: $2.18 SVNTQ Score: -146.28

Loaded up in RL yesterday, I'll take a chance on the destruction.

Recs

0
Member Avatar stainsolution (43.12) Submitted: 4/9/2012 7:40:59 PM : Outperform Start Price: $1.93 SVNTQ Score: -149.61

Chart looks to have bottomed out.

Recs

0
Member Avatar RBuskey106 (50.71) Submitted: 3/15/2012 1:45:39 PM : Outperform Start Price: $1.94 SVNTQ Score: -147.29

looks to have bottomed out.

Recs

0
Member Avatar mcad6641 (< 20) Submitted: 3/15/2012 3:06:40 AM : Outperform Start Price: $1.92 SVNTQ Score: -146.79

Krystexxa big in EU

Recs

0
Member Avatar Itchy16 (< 20) Submitted: 3/6/2012 4:45:27 PM : Outperform Start Price: $1.86 SVNTQ Score: -152.81

Oversold at this level

Recs

1
Member Avatar 1Ning (< 20) Submitted: 2/18/2012 1:42:58 PM : Outperform Start Price: $2.11 SVNTQ Score: -150.95

krystexxa launch.

Recs

0
Member Avatar explainstuff (56.14) Submitted: 12/16/2011 10:12:33 PM : Outperform Start Price: $2.38 SVNTQ Score: -169.30

Market Maker Selling phase soon?

Recs

0
Member Avatar kendricklamar (83.11) Submitted: 11/20/2011 12:44:41 PM : Outperform Start Price: $2.35 SVNTQ Score: -171.73

jcode

Recs

1
Member Avatar jbpontes (27.62) Submitted: 8/25/2011 1:55:54 PM : Outperform Start Price: $3.91 SVNTQ Score: -176.54

The market has oversold biotech shares and this company was also affected. I beat it will growth >100%

Recs

0
Member Avatar ExtremesTracker (59.50) Submitted: 8/7/2011 10:46:58 PM : Outperform Start Price: $4.05 SVNTQ Score: -176.60

4 Fallen Bevo picks that are based in US that have very high short interest and are currently above $1/share.

FRZ, SVNT, JRCC, PCBC

Recs

1
Member Avatar jaugolfer68 (< 20) Submitted: 4/6/2011 1:16:12 PM : Outperform Start Price: $10.61 SVNTQ Score: -154.82

New FDA approved drug sales starting this year.

Recs

1
Member Avatar chimpcontest (< 20) Submitted: 2/21/2011 1:44:42 PM : Outperform Start Price: $9.91 SVNTQ Score: -155.12

Euro247 haiku

Did not sell oh well

Plenty money of their own

Drug demand will grow!

Recs

0
Member Avatar russiangambit (29.40) Submitted: 2/6/2011 4:17:47 PM : Outperform Start Price: $9.63 SVNTQ Score: -157.10

short squeeze ahoy

Recs

0
Member Avatar sdbeck23 (40.09) Submitted: 2/3/2011 8:21:03 PM : Outperform Start Price: $9.83 SVNTQ Score: -157.83

why not

Recs

1
Member Avatar EclecticRecluse (80.31) Submitted: 11/22/2010 7:31:11 AM : Underperform Start Price: $12.17 SVNTQ Score: +172.53

Extremely High Price for Book Value

Recs

0
Member Avatar Brisking (< 20) Submitted: 11/18/2010 1:13:45 PM : Outperform Start Price: $12.10 SVNTQ Score: -171.66

When Savient get their sales team together and prove that the gout drug is a winner, they should become a play once again for the major pharmas.

Recs

0
Member Avatar dmdurback10 (< 20) Submitted: 10/25/2010 5:57:02 PM : Outperform Start Price: $12.29 SVNTQ Score: -174.85

The stock completely overacted

Recs

2
Member Avatar randomtask16 (93.84) Submitted: 10/25/2010 11:39:13 AM : Underperform Start Price: $20.05 SVNTQ Score: +173.27

Limited pipeline, Niche Drugs and stingy FDA are keeping me away from this one for now.

Recs

0
Member Avatar dchersey1 (< 20) Submitted: 9/17/2010 3:58:56 PM : Outperform Start Price: $20.59 SVNTQ Score: -183.58

savients capitalization will increase greatly. The Ktyess drug will be used by phys. immensely. Their could be a twist in its use| dchersey1

Results 1 - 20 of 65 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement